UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Effect of pharmacological wash-out in patients undergoing exercise testing after acute myocardial infarction

International journal of cardiology, 2004-11, Vol.97 (2), p.277-281

2004

Link zum Volltext

Verfügbarkeit prüfen

Congenital coronary anomalies in Takotsubo-like syndrome: a rare association

Journal of cardiovascular medicine (Hagerstown, Md.), 2013-01, Vol.14 (1), p.66

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Contrast‐induced Nephropathy: A Single Center Randomized Study

Clinical cardiology (Mahwah, N.J.), 2010-03, Vol.33 (3), p.E63-E68

2010

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome

Journal of cardiovascular medicine (Hagerstown, Md.), 2007-03, Vol.8 (3), p.201

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance and Evolution of Late Ventricular Potentials in the First Year After Myocardial Infarction: A Prospective Study

Pacing and clinical electrophysiology, 1989-01, Vol.12 (P1), p.41-51

1989

Link zum Volltext

Verfügbarkeit prüfen

Ventricular Late Potentials Are Associated with the Presence of Viable Myocardium After Anterior Myocardial Infarction

Annals of noninvasive electrocardiology, 2000-04, Vol.5 (2), p.172-178

2000

Link zum Volltext

Verfügbarkeit prüfen

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study

Therapeutic advances in urology, 2023-01, Vol.15, p.17562872231187216-17562872231187216

2023

Link zum Volltext

Verfügbarkeit prüfen

Collecting ducts carcinoma: In depth exploration and biologically driven therapy (CICERONE)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS754-TPS754

2023

Link zum Volltext

Verfügbarkeit prüfen

APPROACH trial: Multimodal approach in patients with mHSPC: A pragmatic, randomized, phase 3 trial of androgen-deprivation therapy (ADT) plus apalutamide (APA) versus ADT plus apalutamide (APA) and local treatment—Meet-URO 29 study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5115-TPS5115

2023

Link zum Volltext

Verfügbarkeit prüfen

Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma

Current oncology reports, 2023-06, Vol.25 (6), p.671-677

2023

Link zum Volltext

Verfügbarkeit prüfen

MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

Journal of clinical pathology, 2022-01, Vol.75 (1), p.39

2022

Link zum Volltext

Verfügbarkeit prüfen

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

Expert review of anticancer therapy, 2023-05, Vol.23 (5), p.545-554

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Cancers, 2019-12, Vol.12 (1), p.84

2019

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

Journal of personalized medicine, 2022-04, Vol.12 (5), p.727

2022

Link zum Volltext

Verfügbarkeit prüfen

Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15594-e15594

2015

Link zum Volltext

Verfügbarkeit prüfen

Class Struggle

Afterlives of Chinese Communism, 2019, p.29

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(21)
Buchkapitel
(1)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Humans
(12)
Female
(8)
Male
(8)
Aged
(6)
Kidney Neoplasms - Pathology
(6)
Oncology
(6)
Carcinoma, Renal Cell - Drug Therapy
(5)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular System & Cardiology
(5)
Kidney Cancer
(5)
Metastasis
(5)
Middle Aged
(5)
Renal Cell Carcinoma
(5)
Retrospective Studies
(5)
Cabozantinib
(4)
Kidney Neoplasms - Drug Therapy
(4)
Medical Prognosis
(4)
Metastatic Renal Cell Carcinoma
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of pharmacological wash-out in patients undergoing exercise testing after acute myocardial infarction

Congenital coronary anomalies in Takotsubo-like syndrome: a rare association

Prevention of Contrast‐induced Nephropathy: A Single Center Randomized Study

Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome

Prognostic Significance and Evolution of Late Ventricular Potentials in the First Year After Myocardial Infarction: A Prospective Study

Ventricular Late Potentials Are Associated with the Presence of Viable Myocardium After Anterior Myocardial Infarction

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study

Collecting ducts carcinoma: In depth exploration and biologically driven therapy (CICERONE)

Activity of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy: Interim results from the phase 2 ARCADIA trial

APPROACH trial: Multimodal approach in patients with mHSPC: A pragmatic, randomized, phase 3 trial of androgen-deprivation therapy (ADT) plus apalutamide (APA) versus ADT plus apalutamide (APA) and local treatment—Meet-URO 29 study

Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

Complete remission (CR) during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs)

Class Struggle

Suchergebnisse filtern